<?xml version="1.0" encoding="UTF-8"?>
<ref id="B65-pathogens-09-00231">
 <label>65.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kraft</surname>
    <given-names>C.S.</given-names>
   </name>
   <name>
    <surname>Hewlett</surname>
    <given-names>A.L.</given-names>
   </name>
   <name>
    <surname>Koepsell</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Winkler</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Kratochvil</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Larson</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Varkey</surname>
    <given-names>J.B.</given-names>
   </name>
   <name>
    <surname>Mehta</surname>
    <given-names>A.K.</given-names>
   </name>
   <name>
    <surname>Lyon</surname>
    <given-names>G.M.</given-names>
   </name>
   <name>
    <surname>Friedman-Moraco</surname>
    <given-names>R.J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The Use of TKM-100802 and Convalescent Plasma in 2 Patients with Ebola Virus Disease in the United States</article-title>
  <source>Clin. Infect. Dis.</source>
  <year>2015</year>
  <volume>61</volume>
  <fpage>496</fpage>
  <lpage>502</lpage>
  <pub-id pub-id-type="doi">10.1093/cid/civ334</pub-id>
  <pub-id pub-id-type="pmid">25904375</pub-id>
 </element-citation>
</ref>
